Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease. Wellens J, Brann S, Adams A, Marlow L, et al. Lancet Gastroenterol Hepatol 2022 Apr 6. pii: S2468-1253(22)00120.

Read + Share

Amedeo Smart

Independent Medical Education

Wellens J, Brann S, Adams A, Marlow L, et al. Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease. Lancet Gastroenterol Hepatol 2022 Apr 6. pii: S2468-1253(22)00120.
PMID: 35397229